-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Pharmaceutical Manufacturers
-
Hospital and Healthcare Providers
-
Pharmacy
-
Governments
-
Private Payers and Insurers
-
Academics and Researchers
Pharmaceutical Manufacturers
Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.
Learn MorePHARMACEUTICAL MANUFACTURERS QUICK LINKS
Hospital and Healthcare Providers
Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.
Learn MorePharmacy
A specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.
Learn MorePHARMACY QUICK LINKS
Governments
Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn More
Private Payers and Insurers
Health benefit analytics for effective response to market changes.
Learn More
Academics and Researchers
Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.
Learn MoreINSIGHTS
Explore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.
Learn MorePHARMACEUTICAL TRENDS
Media representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.
Learn More
CAREERS CANADA
Why work at IQVIA Canada? Help create a healthier world; start right here where we offer a diversity of opportunities.
DISCOVER CAREERSOUR CULTURE
Our passion to make an impact is fueled by the people we work with, a curiosity to bring new ideas to life, and a focus on always doing better.
LEARN MORE
UNLEASH YOUR POTENTIAL
"Join IQVIA and see where your skills and competencies can take you.
APPLY NOWFact Sheet
Trends in the use of antipsychotics in Canada, 2019–2022
IQVIA Snapshot - Prevalence and Treatment of Mental Health Disorders
Feb 16, 2024
This Snapshot presents some highlights obtained from IQVIA’s Dashboard on prescriptions dispensed for antipsychotics. The data used to produce this Snapshot includes the two existing generations of antipsychotics: first-generation (typical) antipsychotics, which are used increasingly less and whose volumes in the data studied are the first and second-generation (atypical) antipsychotics, which, in oral form, are by far the most widely used. This generation also includes long-lasting injections (depot form), which are dispensed between once a week and once a month. Prevalence and demographic characteristics of consumption in the general Canadian population are presented for 2019, 2020, 2021, and 2022.